Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Yoko Tokuyama"'
Autor:
Hideaki Kawabata, Kazumi Kitamura, Yoshiki Yamamoto, Yohei Okamoto, Ayaka Shimaji, Kaoru Aoki, Yoko Kato, Yoko Tokuyama, Yoshihiro Shimizu
Publikováno v:
Journal of Medical Cases. 10:75-77
Autor:
Kaori Aoki, Yohei Okamoto, Yoshiko Hirayama, Kazumi Kitamura, Yoshihiro Shimizu, Yoko Tokuyama, Yoshiki Yamamoto, Hideaki Kawabata
Publikováno v:
Journal of Palliative Medicine. 23:1419-1420
Autor:
Hiroko Kawara, Yusuke Noguchi, Yoshihiro Shimizu, Kiyoshi Uchiyama, Yoko Tokuyama, Yugo Kawashima, Megumi Maruyama
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(3)
Purpose Docetaxel is known to cause eye disorders. In this study, current status of eye disorders caused by docetaxel administration every 3 weeks in Japanese patients was examined. Methods This case-control study targeted patients who were newly adm
Autor:
Naho Atsumi, Keiki Kumano, Yoko Tokuyama, Tadashi Matsuda, Naoko Yoshida, Toshihiro Tanaka, Hiroko Hisha, Shuichi Ohe, Hirotsugu Yanai, Yoshihiro Komai, Hiroo Ueno, Taichi Omachi
Publikováno v:
The Journal of Kansai Medical University. 67:1-7
Autor:
Megumi Maruyama, Kiyoshi Uchiyama, Yugo Kawashima, Yusuke Noguchi, Yoshihiro Shimizu, Hiroko Kawara, Yoko Tokuyama
Publikováno v:
Biologicalpharmaceutical bulletin. 41(11)
Paclitaxel and nanoparticle albumin-bound paclitaxel are known to cause adverse events of eye disorders, such as cystoid macular edema. However, at present, the risk factors remain unclear. Therefore, risk factors for eye disorders caused by paclitax
Autor:
Naho Atsumi, Yoshihiro Komai, Yoko Tokuyama, Hiroyuki Okamoto, Keiki Kumano, Shuichi Ohe, Haruyuki Ohsugi, Kiyomichi Tanaka, Shohei Kanno, Toshihiro Tanaka, Naohiro Nakamura, Fumikazu Yamazaki, Hirotsugu Yanai, Kazuhiko Ishigaki, Kazuho Saiga, Naoko Yoshida, Taichi Omachi, Hiroko Hisha, Hiroo Ueno
Publikováno v:
Biochemical and Biophysical Research Communications. 466:333-338
The skin is responsible for a variety of physiological functions and is critical for wound healing and repair. Therefore, the regenerative capacity of the skin is important. However, stem cells responsible for maintaining the acral epithelium had not
Autor:
Yoko Tokuyama, Masanori Kon, Keiki Kumano, Toshihiro Tanaka, Haruyuki Ohsugi, Kiyomichi Tanaka, Hiroo Ueno, Hirotsugu Yanai, Shuichi Ohe, Kazuhiko Ishigaki, Yuki Imahashi, Taichi Omachi, Kazuho Saiga, Naoko Yoshida, Hiroko Hisha, Yoshihiro Komai, Naho Atsumi, Naohiro Nakamura
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
The murine intestine, like that of other mammalians, continues to develop after birth until weaning; however, whether this occurs in response to an intrinsic developmental program or food intake remains unclear. Here, we report a novel system for the
Autor:
Masanori Kon, Naohiro Nakamura, Keiki Kumano, Hiroko Hisha, Kazuhiko Ishigaki, Hirotsugu Yanai, Hiroo Ueno, Yuki Imahashi, Taichi Omachi, Toshihiro Tanaka, Haruyuki Ohsugi, Kiyomichi Tanaka, Yoshihiro Komai, Shuichi Ohe, Kazuho Saiga, Naoko Yoshida, Naho Atsumi, Yoko Tokuyama
Publikováno v:
Scientific Reports
Although the existence of cancer stem cells in intestine tumors has been suggested, direct evidence has not been yet provided. Here, we showed, using the multicolor lineage-tracing method and mouse models of intestinal adenocarcinoma and adenoma that
Autor:
Yusuke, Noguchi, Yugo, Kawashima, Hiroko, Kawara, Masatomo, Kaneko, Hiroo, Nakauchi, Yoko, Tokuyama
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 43(6)
Cabazitaxelis a taxane-type antineoplastic agent used for treating prostate cancer. Although typical side effects include neutropenia and fatigue, no studies have investigated eye disorders as a possible side effect, and the details are not clear. He
Autor:
Yusuke, Noguchi, Yugo, Kawashima, Hiroko, Kawara, Yoko, Tokuyama, Yoshiko, Tamura, Kiyoshi, Uchiyama, Yoshihiro, Shimizu
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 43(6)
Docetaxel is an antineoplastic agent used to treat breast cancer and several other types of cancer. Typical adverse drug reactions with docetaxel include myelosuppression and edema, but there have also been numerous reports of eye disorders, such as